Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,570.00
-110.00 (-1.65%)
Oct 10, 2025, 3:30 PM KST
-1.65%
Market Cap387.04B
Revenue (ttm)89.16B
Net Income (ttm)16.21B
Shares Out58.91M
EPS (ttm)241.25
PE Ratio27.23
Forward PEn/a
Dividend50.00 (0.75%)
Ex-Dividend DateDec 27, 2024
Volume579,651
Average Volume1,001,273
Open6,710.00
Previous Close6,680.00
Day's Range6,410.00 - 6,710.00
52-Week Range4,385.00 - 8,420.00
Beta0.56
RSI48.36
Earnings DateNov 14, 2025

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2003
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 099430
Full Company Profile

Financial Performance

In 2024, Bio Plus's revenue was 66.41 billion, an increase of 2.10% compared to the previous year's 65.04 billion. Earnings were 14.15 billion, a decrease of -44.68%.

Financial Statements

News

There is no news available yet.